By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the life science 'omics tools and molecular diagnostics space rose 15 percent year over year for the first half of 2011, spurred on by the low cost of debt and a handful of companies that proved to be especially aggressive buyers.

Despite the uptick, though, the M&A environment remains mixed and the forecast for the near future is unclear, according to industry observers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.